NGDI Collaborates with UCSF for WHO Contract

The World Health Organization is funding a collaboration with the Neglected Global Diseases Initiative and the University of California San Franciso for a Review of Pediatric Medicines in Lower-Middle Income Countries and Adverse Clinical Outcomes.

This short term contract is the first outcome from a visit from the WHO co-sponsored by the NGDI in August, 2010 by Dr. Clive Ondari, Coordinator of Medicines Access and Rational Use clinical team.   Dr. Lisa Bero, Professor, Department of Clinical Pharmacy, School of Pharmacy and Co-Director, San Francisco Branch United States Cochrane Center.

The review will answer the questions:

  • What is the extent of poor quality pediatric medicines, as measured by failure to adhere to quality standards?
  • Are poor quality standards associated with a particular level in the distribution channel (or other characteristics)?

The draft report is due by the end of March, 2012.